Engineered antibodies targeted to bacterial surface integrate effector functions with toxin neutralization to provide superior efficacy against bacterial infections.
Adhikari RP, Alem F, Kemboi D, Kanipakala T, Sherchand SP, Kailasan S, Purcell BK, Heine HS, Russell-Lodrigue K, Etobayeva I, Howell KA, Vu H, Shulenin S, Holtsberg FW, Roy CJ, Hakami RM, Nelson DC, Aman MJ.
Adhikari RP, et al. Among authors: sherchand sp.
medRxiv [Preprint]. 2024 Sep 25:2024.09.23.24313920. doi: 10.1101/2024.09.23.24313920.
medRxiv. 2024.
PMID: 39398995
Free PMC article.
Preprint.